Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population
Masato Furuhashi, Megumi Matsumoto, Marenao Tanaka, et al.
Circulation Journal (2018) Vol. 82, Iss. 7, pp. 1892-1899
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Masato Furuhashi
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 5, pp. E827-E834
Closed Access | Times Cited: 246
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Masato Furuhashi
Journal of Atherosclerosis and Thrombosis (2019) Vol. 26, Iss. 3, pp. 216-232
Open Access | Times Cited: 237
Uric Acid and Chronic Kidney Disease: Still More to Do
Richard J. Johnson, Laura Gabriela Sánchez‐Lozada, Miguel A. Lanaspa, et al.
Kidney International Reports (2022) Vol. 8, Iss. 2, pp. 229-239
Open Access | Times Cited: 77
Natural compounds lower uric acid levels and hyperuricemia: Molecular mechanisms and prospective
Simin Feng, Sijie Wu, Fei Xie, et al.
Trends in Food Science & Technology (2022) Vol. 123, pp. 87-102
Open Access | Times Cited: 71
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 42
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Impact of Hyper- and Hypo-Uricemia on Kidney Function
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Marenao Tanaka, Kazuma Mori, Satoko Takahashi, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 700-711
Closed Access | Times Cited: 38
Purine metabolism in the development of osteoporosis
Keda Yang, Jie Li, Lin Tao
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113784-113784
Open Access | Times Cited: 33
High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Göttingen Minipigs
Ditte Olsen Lützhøft, Cecilie Bækgård, Elizabeth A. Wimborne, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0298602-e0298602
Open Access | Times Cited: 8
Differential regulation of hypoxanthine and xanthine by obesity in a general population
Masato Furuhashi, Masayuki Koyama, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2020) Vol. 11, Iss. 4, pp. 878-887
Open Access | Times Cited: 49
Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease ― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―
Ichiro Hisatome, Peili Li, Junichiro Miake, et al.
Circulation Journal (2020) Vol. 85, Iss. 2, pp. 130-138
Open Access | Times Cited: 42
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2
Kazuma Mori, Masato Furuhashi, Marenao Tanaka, et al.
Hypertension Research (2020) Vol. 44, Iss. 1, pp. 107-116
Closed Access | Times Cited: 41
Hyperuricemia, Gout, and the Brain—an Update
Augustin Latourte, Julien Dumurgier, Claire Paquet, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Masato Furuhashi, Megumi Matsumoto, Takayo Murase, et al.
Journal of Diabetes Investigation (2018) Vol. 10, Iss. 4, pp. 1059-1067
Open Access | Times Cited: 43
Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects
Satoko Takahashi, Marenao Tanaka, Masato Furuhashi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 14
Open Access | Times Cited: 28
Effects of febuxostat therapy on circulating adipokine profiles in patients with overweight or obesity and asymptomatic hyperuricemia: A randomized controlled study
Meijuan Dong, Zhaohui Cui, Yuanyuan Liu, et al.
Obesity Facts (2024) Vol. 17, Iss. 5, pp. 524-534
Open Access | Times Cited: 4
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease
Avi Goldberg, Fernando E. García‐Arroyo, Fumihiko Sasai, et al.
American Journal of Nephrology (2021) Vol. 52, Iss. 10-11, pp. 837-844
Open Access | Times Cited: 25
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 18
Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
Marenao Tanaka, Satoko Takahashi, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2021) Vol. 13, Iss. 5, pp. 878-888
Open Access | Times Cited: 23
Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome
Yuya Fujishima, Shunbun Kita, Hitoshi Nishizawa, et al.
Endocrine Journal (2023) Vol. 70, Iss. 7, pp. 663-675
Open Access | Times Cited: 9
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort
Marenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2635-2645
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top